ArticleMikrochimica acta2026
Development of a rapid metal oxide semiconductor-based sensory system for noninvasive neonatal sepsis detection.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A portable electronic nose system, termed cNose, is presented which combines an optimized metal oxide semiconductor gas sensor array with machine learning algorithms to determine fecal volatile organic compounds (VOCs) for noninvasive bedside screening of neonatal sepsis. The system was evaluated at a public hospital in Sleman, Yogyakarta, Indonesia, using 347 fecal samples (197 positive, 150 negative for sepsis confirmed by blood culture). This balanced dataset was used for exploratory machine learning analysis and proof-of-concept evaluation rather than for population-level inference. Features from averaged sensor responses served as inputs for four classifiers: linear discriminant analysis (LDA), decision tree, random forest, and extreme gradient boosting. Mutual information-based feature selection was employed to identify the most informative sensors to reduce redundancy in the array. Cross-validation on the training set indicated that mutual information combined with LDA achieved accuracy, sensitivity, and specificity of 91.42% (95% CI: 85.53–97.30%), 90.39% (95% CI: 84.19–96.58%), and 3.04% (95% CI: 87.70–98.39%), respectively, using only six sensors. On the independent testing dataset, the model achieved 89.41% (95% CI: 82.87–95.95%) accuracy, 89.36% (95% CI: 82.81–95.92%) sensitivity, and 89.47% (95% CI: 82.95–96.00%) specificity. The findings of this study suggest that cNose could serve as a low-cost, rapid, and noninvasive screening tool, potentially reducing sampling and analysis time compared to conventional blood tests.
Indexed as
Identifiers
41654677What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.